reviewThe LancetAug 1, 2014Closed access

HDL and cardiovascular disease

DJDaniel J. Rader GKG. Kees Hovingh

Translational Therapeutics (United States) · University of Pennsylvania · +2 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

865

total citations

FWCI: 54.79
Percentile: 100%
References: 85

Citations per year

Authors

2

DJ
Daniel J. RaderCorresponding
Translational Therapeutics (United States), University of Pennsylvania
GK
G. Kees Hovingh
University of Amsterdam, Academic Medical Center

Topics & keywords

Topics

Keywords

Cholesterylester transfer protein
Medicine
Disease
Cholesterol
Coronary heart disease
Clinical trial
Reverse cholesterol transport
Internal medicine

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.